SCHEMBL3903710

SCHEMBL3903710

CCC/C=C/c1c(O)c(Cl)c(C)c(C=O)c1O

nearest known ligand 0.43

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ TYMP P19971 1/20 0.39
▸ DHODH Q02127 12/20 0.37
▸ OPRM1 P35372 1/20 0.35
▸ MAOB P27338 1/20 0.33
▸ IGF1R P08069 1/20 0.31
▸ SRC P12931 1/20 0.31
▸ AXL P30530 1/20 0.31
▸ PTK2 Q05397 1/20 0.31
▸ AURKB Q96GD4 1/20 0.31
▸ ALK Q9UM73 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3903713 1.00 TYMP (0.39) TYMPDHODHOPRM1MAOBIGF1R
SCHEMBL3900983 0.90 OPRM1 (0.46) DHODHOPRM1
SCHEMBL3900984 0.90 OPRM1 (0.46) DHODHOPRM1
SCHEMBL3908785 0.88 OPRM1 (0.45) OPRM1
SCHEMBL3900977 0.88 OPRM1 (0.45) OPRM1
SCHEMBL3897938 0.88 OPRM1 (0.45) OPRM1
SCHEMBL3900975 0.88 OPRM1 (0.45) OPRM1
SCHEMBL3908788 0.88 OPRM1 (0.45) OPRM1
SCHEMBL28818537 0.82 DHODH (0.36) DHODHOPRM1MAOB
SCHEMBL28009777 0.81 DHODH (0.35) DHODHOPRM1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2857010-B1 DIHYDROOROTIC ACID DEHYDROGENASE INHIBITOR INST OF MITOCHONDRIA SCIENCE INC (JP) 2018-07-04 — — EP disclosed
US-7622598-B2 Phenol derivatives and antitrypanosoma preventive/therapeutic agent comprising the same as active ingredient ARIGEN PHARMACEUTICALS, INC. (JP) 2009-11-24 — — US disclosed
US-7622598-B2 Phenol derivatives and antitrypanosoma preventive/therapeutic agent comprising the same as active ingredient ARIGEN PHARMACEUTICALS, INC. (JP) 2009-11-24 — — US disclosed
US-7622598-B2 Phenol derivatives and antitrypanosoma preventive/therapeutic agent comprising the same as active ingredient ARIGEN PHARMACEUTICALS, INC. (JP) 2009-11-24 — — US disclosed
EP-1681280-B1 NOVEL PHENOL DERIVATIVES AND ANTITRYPANOSOMA PREVENTIVE/THERAPEUTIC AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT ARIGEN PHARMACEUTICALS INC (JP) 2009-03-25 — — EP disclosed
US-20070208078-A1 NOVEL PHENOL DERIVATIVES AND ANTITRYPANOSOMA PREVENTIVE/THERAPEUTIC AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT ARIGEN, INC. (JP) 2007-09-06 — — US disclosed
US-20070208078-A1 NOVEL PHENOL DERIVATIVES AND ANTITRYPANOSOMA PREVENTIVE/THERAPEUTIC AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT ARIGEN, INC. (JP) 2007-09-06 — — US disclosed
US-20070208078-A1 NOVEL PHENOL DERIVATIVES AND ANTITRYPANOSOMA PREVENTIVE/THERAPEUTIC AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT ARIGEN, INC. (JP) 2007-09-06 — — US disclosed
EP-1681280-A1 NOVEL PHENOL DERIVATIVES AND ANTITRYPANOSOMA PREVENTIVE/THERAPEUTIC AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT aRigen, Inc. (JP) 2006-07-19 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070208078-A1 NOVEL PHENOL DERIVATIVES AND ANTITRYPANOSOMA PREVENTIVE/THERAPEUTIC AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT TYR, H1-3, H1-0 TYMP 981/4885DHODH 698/4885OPRM1 2281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback